References
- Maurice DM. The use of fluorescein in ophthalmological research. Invest Ophthalmol 1967; 6: 464–77.
- Bartlett JD, Jaanus SD. Clinical ocular pharmacology. 4th Edition. London: Butterworth-Heineman.
- Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases. Ophthalmology 2003; 110(1): 15–21.
- Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green as related to angiography. Surv Ophthalmol 2000; 45(1): 15–27.
- Regillo CD. The present role of indocyanine green angio-graphy in ophthalmology. Curr Opin Ophthalmol 1999; 10(3): 189–96.
- Ben-Sira I, Riva CE. Fluorescein diffusion in the human optic disc. Invest Ophthalmol 1975; 14(3): 205–11.
- Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein angiographic lesion type frequency in neovas-cular age-related macular degeneration. Ophthalmology 2004; 111(2): 250–5.
- Battaglia Parodi M, Pozzo SD, Ravalico G. Angiographic pattern of recurrent choroidal neovascularisation in age-related macular degeneration. Eye 2004; 23.
- Cevallerano AA. Ophthalmic fluorescein angiography. Optometry Clin 1996; 5(1): 1–23.
- Fineman MS, Maguire JI, Fineman SW, Benson WE. Safety of indocyanine green angiography during pregnancy. Arch Ophthalmol 2001; 119(3): 353–5.
- Kim J. The use of vital dyes in corneal disease. Curr Opin Ophthalmol 2000; 11(4): 241–7.
- Crook TG. Fluorescein as an aid in pachymetry. Am J Optometry Physiol Optics 1979; 56(2): 124–7.
- Korb DR. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000; 19(4): 483–6.
- Akman A, Akova YA. Trypan-blue-assisted capsulorrhexis for trainee phakoemulsification surgeons. J Cataract Refractive Surg 2003; 29(5): 861–2.
- Saine SJ. Landmarks in the historical development of fluorescein angiography. J Ophthalmic Photography 1993; 15(1): 17–23.